MannKind Corp
MNKD
#4917
Rank
โ‚ฌ1.49 B
Marketcap
4,88ย โ‚ฌ
Share price
-0.53%
Change (1 day)
-23.27%
Change (1 year)

Revenue for MannKind Corp (MNKD)

Revenue in 2025 (TTM): โ‚ฌ0.28 Billion

According to MannKind Corp's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.26 Billion. In 2024 the company made a revenue of โ‚ฌ0.27 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MannKind Corp from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.28 B2.46%
2024 โ‚ฌ0.27 B52.44%
2023 โ‚ฌ0.17 B93.51%
2022 โ‚ฌ93.01 M39.62%
2021 โ‚ฌ66.61 M25.78%
2020 โ‚ฌ52.96 M-5.88%
2019 โ‚ฌ56.27 M131.08%
2018 โ‚ฌ24.35 M148.78%
2017 โ‚ฌ9.78 M-94.11%
2016 โ‚ฌ0.16 B
2015 N/A
2014 N/A
2013 N/A-100%
2012 โ‚ฌ0.02 M-31.28%
2011 โ‚ฌ0.03 M-44.93%
2010 โ‚ฌ0.06 M
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Halozyme Therapeutics
HALO
โ‚ฌ1.06 B 296.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚ฌ40.55 B 14,945.74%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Merck
MRK
โ‚ฌ55.17 B 20,370.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ51.03 B 18,836.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚ฌ53.76 M-80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.92 B 19,909.11%๐Ÿ‡บ๐Ÿ‡ธ USA